Baylor College of Medicine at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Baylor College of Medicine brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on how CAR T cells are designed and built, from TCR-like receptor architectures to transgene arrangements that carry very large payloads in lymphoma. One strand combines a TRAC knock-in with CD2 disruption so anti-CD2 cells do not kill each other.

OrganizationESGCT 2026 Attendance
Universities & institutes
Medical school whose Center for Cell and Gene Therapy develops CAR-T and virus-specific T-cell therapies.
Poster
Wed Oct 28
1:30pm–3:30pm
Expression of co-stimulatory ligands on tumor cells determines in vivo efficacy of TCR-like CAR architectures but not conventional second-generation CAR T cells
Immunotherapy and CAR T cells
Poster
Wed Oct 28
1:30pm–3:30pm
Simultaneous TRAC knock-in and CD2 disruption via orthogonal CRISPR enzymes generates fratricide-resistant anti-CD2 CAR T cells
Immunotherapy and CAR T cells
Poster
Thu Oct 29
2:00pm–4:00pm
Transgene syntax and integration site enable expression of super-large payloads and drive multi-functional CAR T cell potency in lymphoma.
Immunotherapy and CAR T cells
Chair
Thu Oct 29
4:00pm–6:00pm
SESSION 9c: Immunotherapy and CAR T cells III
with University of Zurich, Erasmus MC
Cell therapies and CAR-T

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Baylor College of Medicine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction